Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted

December 20, 2023

Please see attachment.

Contact information

Investor RelationsDisa Tuominen+45 6038 5826dkditu@chr-hansen.com

Press RelationsSanne Seyer-Hansen+45 6038 6207dksash@chr-hansen.com

Attachment

  • 2023_South Korean merger approval granted
Chr Hansen (TG:51C)
Historical Stock Chart
Von Okt 2024 bis Nov 2024 Click Here for more Chr Hansen Charts.
Chr Hansen (TG:51C)
Historical Stock Chart
Von Nov 2023 bis Nov 2024 Click Here for more Chr Hansen Charts.